JP2024532263A5 - - Google Patents
Info
- Publication number
- JP2024532263A5 JP2024532263A5 JP2024512007A JP2024512007A JP2024532263A5 JP 2024532263 A5 JP2024532263 A5 JP 2024532263A5 JP 2024512007 A JP2024512007 A JP 2024512007A JP 2024512007 A JP2024512007 A JP 2024512007A JP 2024532263 A5 JP2024532263 A5 JP 2024532263A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236035P | 2021-08-23 | 2021-08-23 | |
| US63/236,035 | 2021-08-23 | ||
| US202263297908P | 2022-01-10 | 2022-01-10 | |
| US63/297,908 | 2022-01-10 | ||
| US202263319500P | 2022-03-14 | 2022-03-14 | |
| US63/319,500 | 2022-03-14 | ||
| US202263341948P | 2022-05-13 | 2022-05-13 | |
| US63/341,948 | 2022-05-13 | ||
| PCT/US2022/075311 WO2023028468A1 (en) | 2021-08-23 | 2022-08-23 | Methods for treating atopic dermatitis by administering an il-4r antagonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532263A JP2024532263A (ja) | 2024-09-05 |
| JPWO2023028468A5 JPWO2023028468A5 (https=) | 2025-09-01 |
| JP2024532263A5 true JP2024532263A5 (https=) | 2025-09-01 |
Family
ID=83280357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512007A Pending JP2024532263A (ja) | 2021-08-23 | 2022-08-23 | Ｉｌ－４ｒアンタゴニストを投与することによってアトピー性皮膚炎を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167171A1 (https=) |
| EP (1) | EP4392450A1 (https=) |
| JP (1) | JP2024532263A (https=) |
| KR (1) | KR20240049351A (https=) |
| AU (1) | AU2022333073A1 (https=) |
| CA (1) | CA3227014A1 (https=) |
| IL (1) | IL310962A (https=) |
| MX (1) | MX2024002072A (https=) |
| WO (1) | WO2023028468A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2892927T3 (pl) | 2012-09-07 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R |
| CN114173816A (zh) | 2019-08-05 | 2022-03-11 | 瑞泽恩制药公司 | 通过施用il-4r拮抗剂治疗特应性皮炎的方法 |
| WO2025088063A2 (en) * | 2023-10-24 | 2025-05-01 | Sanofi | Systems and methods for monitoring a medicament dosing schedule |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2990420B1 (en) | 2000-05-26 | 2016-12-21 | Immunex Corporation | Use of interleukin-4 receptor antibodies and compositions thereof |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| MXPA06004853A (es) | 2003-11-07 | 2006-07-06 | Immunex Corp | Anticuerpos que se aglutinan al receptor 4 de interleucina. |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| CN101522716B (zh) | 2006-10-02 | 2013-03-20 | 瑞泽恩制药公司 | 抗人il-4受体的高亲和力人抗体 |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| BR112013008366B1 (pt) | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| PL2892927T3 (pl) | 2012-09-07 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R |
| ES2983475T3 (es) * | 2016-02-19 | 2024-10-23 | Regeneron Pharma | Métodos para mejorar la eficacia de una vacuna mediante la administración de un antagonista de IL-4R |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| WO2018057776A1 (en) | 2016-09-22 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN112010977B (zh) | 2019-05-29 | 2022-04-26 | 山东博安生物技术股份有限公司 | 抗白介素4受体(il-4r)的抗体及其应用 |
| IL296214A (en) | 2020-03-27 | 2022-11-01 | Regeneron Pharma | Methods for treating atopic dermatitis by administering an il-4r antagonist |
| CN114555639B (zh) | 2020-09-10 | 2023-12-12 | 舒泰神（北京）生物制药股份有限公司 | 特异性识别白细胞介素-4受体α的抗体及其用途 |
| EP4019547A1 (en) | 2020-12-23 | 2022-06-29 | Numab Therapeutics AG | Multispecific antibodies having specificity for il-4r and il-31 |
| KR20230123993A (ko) | 2020-12-23 | 2023-08-24 | 누맙 세러퓨틱스 아게 | Il-31에 결합하는 항체 가변 도메인 |
-
2022
- 2022-08-23 WO PCT/US2022/075311 patent/WO2023028468A1/en not_active Ceased
- 2022-08-23 CA CA3227014A patent/CA3227014A1/en active Pending
- 2022-08-23 KR KR1020247009788A patent/KR20240049351A/ko active Pending
- 2022-08-23 AU AU2022333073A patent/AU2022333073A1/en active Pending
- 2022-08-23 EP EP22769062.5A patent/EP4392450A1/en active Pending
- 2022-08-23 JP JP2024512007A patent/JP2024532263A/ja active Pending
- 2022-08-23 US US17/821,665 patent/US20230167171A1/en active Pending
- 2022-08-23 IL IL310962A patent/IL310962A/en unknown
- 2022-08-23 MX MX2024002072A patent/MX2024002072A/es unknown